Daraxonrasib: Shifting the Paradigm in Metastatic Pancreatic Cancer

from TheBrief.Health · host TheBrief.Health

Daraxonrasib significantly improves survival, disease control, and quality of life in metastatic pancreatic cancer, marking a major advance in targeted second-line treatment options.

Episode metadata supplied by the publisher feed · Published Jun 4, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Daraxonrasib: Shifting the Paradigm in Metastatic Pancreatic Cancer

0:00 1:37

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 1 minute long.

When was this TheBrief.Health episode published?

This episode was published on June 4, 2026.

Can I download this TheBrief.Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!